Authors

• Rensheng Wang (ORCID: https://orcid.org/0000-0002-5010-3855)
• Ye‐Ying Fang (ORCID: https://orcid.org/0000-0002-0598-6011)
• Xiuyuan Lu (ORCID: https://orcid.org/0000-0001-5958-482X)
• Kai Hu
• Jie Ma (ORCID: https://orcid.org/0009-0003-4536-0931)
• Xiwen Liao (ORCID: https://orcid.org/0000-0002-1724-1463)
• Ning Mo (ORCID: https://orcid.org/0000-0003-0786-1113)
• Tingting Zhang (ORCID: https://orcid.org/0000-0002-1919-1471)
• Haiping Zheng (ORCID: https://orcid.org/0000-0001-5438-6744)
• Xiaofang Huang (ORCID: https://orcid.org/0000-0003-3904-8186)
• Jie Zeng
• Cuizhen Liu
• Yanfeng Jiang (ORCID: https://orcid.org/0000-0002-5006-5190)
• Fuchao Ma
• Jinfeng Qiu
• Jing Tang (ORCID: https://orcid.org/0000-0002-0467-2248)
• Yufeng Lv (ORCID: https://orcid.org/0000-0001-5542-1783)
• Li Ye (ORCID: https://orcid.org/0000-0001-7688-4867)
• Liang Li (ORCID: https://orcid.org/0000-0003-0799-2885)
• Lijun Ning
• S. L. Guo (ORCID: https://orcid.org/0000-0001-6952-365X)
• Zhiming Zeng
• Zhendong Yang
• Lihua Yang (ORCID: https://orcid.org/0000-0002-6801-0382)
• Yan Wang (ORCID: https://orcid.org/0000-0002-1743-6383)

Institutions

• Guangxi Medical University (CN)
• First Affiliated Hospital of GuangXi Medical University (CN)
• Bio-Medical Science (South Korea) (KR)
• 303 Hospital of People's Liberation Army (CN)

Publication Details

Journal

Frontiers in Immunology

Published

2025-11-10

DOI

https://doi.org/10.3389/fimmu.2025.1687344

Primary Topic

Hepatocellular Carcinoma Treatment and Prognosis

Type

article

Field-Weighted Citation Impact

0.00